LACHEN, Switzerland - Friday, December 23rd 2016 [ME NewsWire]
(BUSINESS WIRE)-- Octapharma is proud to announce that the company has made a charitable donation of 4.5 million units of its fourth generation, human cell-line derived recombinant factor VIII product, Nuwiq®, to the World Federation of Hematology (WFH) Humanitarian Aid Program.
The lack of access to care in developing countries is an urgent and important public health challenge. The aim of the WFH Humanitarian Aid Program is to provide consistent and predictable access to treatment for all. Through the donation of Nuwiq®, Octapharma is helping to provide access to FVIII therapy in developing countries that may otherwise be unable to fully meet the treatment requirements of all patients.
“The WFH is leading the effort to change the lack of access to treatment products for bleeding disorders in developing countries by providing consistent and predictable access to treatment for all,&r
Read more »